MGMT immunoexpression in aggressive pituitary adenoma and carcinoma

ISSN： 1386-341X

Source： Pituitary, Vol.13, Iss.4, 2010-12, pp. : 367-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MGMT Immunoexpression in Silent Subtype 3 Pituitary Adenomas: Possible Therapeutic Implications

By Fealey Michael Scheithauer Bernd Horvath Eva Erickson Dana Kovacs Kalman McLendon Roger Lloyd Ricardo

Endocrine Pathology, Vol. 21, Iss. 3, 2010-09 ,pp. : 161-165

Humana Press, Inc

Access to resources Recommend Favorite

MGMT immunoexpression in adamantinomatous craniopharyngiomas

By Zuhur Sayid

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 323-327

Springer Publishing Company

Access to resources Recommend Favorite

Ghrelin immunoexpression in pituitary adenomas

By Rotondo Fabio

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 318-322

Springer Publishing Company

Access to resources Recommend Favorite

Immunoexpression of Androgen Receptor in the Nontumorous Pituitary and in Adenomas

By Scheithauer Bernd Kovacs Kalman Zorludemir Suzan Lloyd Ricardo Erdogan Seyda Slezak Jeffrey

Endocrine Pathology, Vol. 19, Iss. 1, 2008-04 ,pp. : 27-33

Humana Press, Inc

Access to resources Recommend Favorite

Quality of Life in Patients with a Pituitary Adenoma

By Johnson Michelle D. Woodburn C.J. Vance Mary Lee

Pituitary, Vol. 6, Iss. 2, 2003-01 ,pp. : 81-87

Springer Publishing Company

Access to resources Recommend Favorite